Fig. 1From: A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancerDiagram of study population and cohort selection, with exclusion criteria described on the right-hand side of the diagram. AFP alpha-fetoprotein, CEA carcinoembryonic antigen, CA19-9, CA125, CA724 carbohydrate antigen 19-9, 125, and 724Back to article page